GLP-1 medications like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda, Victoza) are becoming increasingly common in the U.S., with about 12% of adults having tried them, according to a KFF Health Tracking Poll
TE is: Common Predictable Temporary Not permanent hair loss In bariatric surgery patients who experience rapid, medically-induced weight loss up to 57% develop telogen effluvium , confirming that this type of shedding is driven by weight-loss physiology, not GLP-1 medications themselves
M., Calarge, C., Ferreira, A
doi: 10.4161/psb.6.4.13912 68 SatohK.KondohH.De LeonT
If youre on or about to start a weight-loss journey with semaglutide, we know youll have lots of questions
Weight loss, particularly when accompanied by improved metabolic markers, has been associated with a reduced risk of these cancers